Tower Research Capital (TRC)’s Acurx Pharmaceuticals ACXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.83K | Sell |
|
|||||
|
2025
Q4 | $7.18K | Buy |
|
|||||
|
2025
Q3 | $4.62K | Buy |
|
|||||
|
2025
Q2 | $2.12K | Sell |
|
|||||
|
2025
Q1 | $1.72K | Sell |
|
|||||
|
2024
Q4 | $3.62K | Buy |
|
|||||
|
2024
Q3 | $3.92K | Sell |
|
|||||
|
2024
Q2 | $9.31K | Buy |
|
|||||
|
2024
Q1 | $7.03K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $10.6K | Buy |
|
|||||
|
2023
Q2 | $11.8K | Buy |
|
|||||
|
2023
Q1 | $10K | Hold |
|
|||||
|
2022
Q4 | $12K | Hold |
|
|||||
|
2022
Q3 | $9K | Buy |
|
|||||
|
2022
Q2 | $7K | Sell |
|
|||||
|
2022
Q1 | $11K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $4K | Buy |
|
|||||
|
2021
Q2 | $3K | Buy |
|